54504-70-0
54504-70-0
Chemical Structure
Etofylline clofibrate
- CAS No.: 54504-70-0
- Formula:C19H21ClN4O5
- Molecular Weight:420.85
IUPAC Name: 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)ethyl 2-(4-chlorophenoxy)-2-methylpropanoate
InChIKey: KYAKGJDISSNVPZ-UHFFFAOYSA-N
SMILES: ClC(C=C1)=CC=C1OC(C)(C)C(OCCN2C3=C(N(C(N(C)C3=O)=O)C)N=C2)=O
Biological Activity: Etofylline clofibrate has ypolipidemic and antithrombotic effect. Etofylline clofibrate has an agonistic interaction with intimal PGI2[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Etofylline clofibrate | 99.65% | Etofylline clofibrate has ypolipidemic and antithrombotic effect. Etofylline clofibrate has an agonistic interaction with intimal PGI2. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Etofylline clofibrate (Standard) | ≥98% | Etofylline clofibrate (Standard) is the analytical standard of Etofylline clofibrate. This product is intended for research and analytical applications. Etofylline clofibrate has ypolipidemic and antithrombotic effect. Etofylline clofibrate has an agonistic interaction with intimal PGI2. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
